Recursion Pharmaceuticals, Inc. - Class A Common Stock (NQ:RXRX)
3.474
-0.036
(-1.03%)
Streaming Delayed Price
Updated: 2:39 PM EDT, Apr 27, 2026
Add to My Watchlist
Price and Volume
Detailed Quote| Volume | 7,225,109 |
| Open | 3.460 |
| Bid (Size) | 3.470 (38,400) |
| Ask (Size) | 3.480 (15,900) |
| Prev. Close | 3.510 |
| Today's Range | 3.440 - 3.590 |
| 52wk Range | 2.800 - 7.180 |
| Shares Outstanding | 168,425,907 |
| Dividend Yield | N/A |
Top News
More News
Recursion to Participate in Upcoming Investor Conferences
April 07, 2026
Via GlobeNewswire
Performance
| YTD |
-17.3%
|
-17.3%
|
| 1 Month |
+18.2%
|
+18.2%
|
| 3 Month |
-24.3%
|
-24.3%
|
| 6 Month |
-44.9%
|
-44.9%
|
| 1 Year |
-40.5%
|
-40.5%
|
More News
Read More
1 Beaten-Down AI Stock to Buy and 1 to Avoid ↗
April 01, 2026
Via The Motley Fool
Topics
Artificial Intelligence
Recursion Pharmaceuticals (NASDAQ:RXRX) Soars on Q4 Earnings Beat ↗
February 25, 2026
Via Chartmill
2 AI Healthcare Stocks to Buy Right Now ↗
March 31, 2026
Via The Motley Fool
Topics
Artificial Intelligence
Can This AI Stock Bounce Back in 2026? ↗
March 08, 2026
Via The Motley Fool
Stocks Under $5 to Watch Now: LRMR, RXRX, NDRA, BTQ, CDIO Watch Now!
February 26, 2026
Recursion (RXRX) Q4 2025 Earnings Call Transcript ↗
February 25, 2026
Via The Motley Fool
What's Behind The Jump In Recursion Pharmaceuticals Stock? ↗
February 25, 2026
Via Benzinga
Recursion To Be Featured in HighRes’ Lightning Talk at NVIDIA GTC
February 23, 2026
Via GlobeNewswire
Recursion to Participate in Upcoming Investor Conferences
February 23, 2026
Via GlobeNewswire
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought ↗
February 22, 2026
Via The Motley Fool
Topics
Artificial Intelligence
NVIDIA’s 13F Bombshell: A New AI Power Trio Emerges ↗
February 19, 2026
Via MarketBeat
Topics
Artificial Intelligence
Recursion Pharmaceuticals Stock Drops: What's Behind It? ↗
February 18, 2026
Via Benzinga
This $4 Stock Could Be Your Ticket to Millionaire Status ↗
February 07, 2026
Via The Motley Fool
Topics
Artificial Intelligence
Frequently Asked Questions
Is Recursion Pharmaceuticals, Inc. - Class A Common Stock publicly traded?
Yes, Recursion Pharmaceuticals, Inc. - Class A Common Stock is publicly traded.
What exchange does Recursion Pharmaceuticals, Inc. - Class A Common Stock trade on?
Recursion Pharmaceuticals, Inc. - Class A Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Recursion Pharmaceuticals, Inc. - Class A Common Stock?
The ticker symbol for Recursion Pharmaceuticals, Inc. - Class A Common Stock is RXRX on the Nasdaq Stock Market
What is the current price of Recursion Pharmaceuticals, Inc. - Class A Common Stock?
The current price of Recursion Pharmaceuticals, Inc. - Class A Common Stock is 3.474
When was Recursion Pharmaceuticals, Inc. - Class A Common Stock last traded?
The last trade of Recursion Pharmaceuticals, Inc. - Class A Common Stock was at 04/27/26 02:39 PM ET
What is the market capitalization of Recursion Pharmaceuticals, Inc. - Class A Common Stock?
The market capitalization of Recursion Pharmaceuticals, Inc. - Class A Common Stock is 585.11M
How many shares of Recursion Pharmaceuticals, Inc. - Class A Common Stock are outstanding?
Recursion Pharmaceuticals, Inc. - Class A Common Stock has 585M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
>